Opioid use disorder documented at delivery hospitalization — United States, 1999–2014

Morbidity and Mortality Weekly Report

Volumn 67, Issue 31, 2018, Pages 845-849

  Haight, Sarah C ^a,b   Ko, Jean Y ^a,c   Van Tong, Van T ^a   Bohm, Michele K ^d   Callaghan, William M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c U S PUBLIC HEALTH SERVICE   (United States)

^d NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HOSPITALIZATION; HUMAN; MEDICAL RECORD; OBSTETRIC DELIVERY; OPIATE ADDICTION; PREGNANCY; PREVALENCE; UNITED STATES;

DELIVERY, OBSTETRIC; FEMALE; HOSPITALIZATION; HUMANS; MEDICAL RECORDS; OPIOID-RELATED DISORDERS; PREGNANCY; PREVALENCE; UNITED STATES;

EID: 85051305304     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6731a1     Document Type: Article

References (10)

1. Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol 2015;35:650–5. https://doi.org/10.1038/jp.2015.36
2. Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology 2014;121:1158–65. https://doi.org/10.1097/ALN.0000000000000472
3. Cicero TJ, Ellis MS, Kasper ZA. Increased use of heroin as an initiating opioid of abuse. Addict Behav 2017;74:63–6. https://doi.org/10.1016/j.addbeh.2017.05.030
4. Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP). HCUP-US databases. Rockville, MD: Agency for Healthcare Research and Quality; 2018. https://www.hcup-us.ahrq.gov/databases.jsp
5. Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence syndrome—28 States, 1999–2013. MMWR Morb Mortal Wkly Rep 2016;65:799–802. https://doi.org/10.15585/mmwr.mm6531a2
6. Substance Abuse and Mental Health Services Administration. A collaborative approach to the treatment of pregnant women with opioid use disorders. HHS publication no. (SMA) 16–4978. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016. https://store.samhsa.gov/shin/content//SMA16-4978/SMA16-4978.pdf
7. Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines—United States, 2012. MMWR Morb Mortal Wkly Rep 2014;63:563–8.
8. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA 2016;315:1624–45. https://doi.org/10.1001/jama.2016.1464
9. American College of Obstetricians and Gynecologists; American Society of Addiction Medicine. ACOG committee opinion no. 711: opioid use and opioid use disorder in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; Rockville, MD: American Society of Addiction Medicine; 2017. https://www.acog.org/-/media/Committee-Opinions/Committee-on-Obstetric-Practice/co711.pdf?dmc=1&ts=20180803T1619512856
10. Guttmacher Institute. Substance use during pregnancy—state laws and policies report. Washington, DC: Guttmacher Institute; 2018. https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy